Glipizide Online

How and where to order Glucotrol and Glucotrol-XL (Glipizide) 5 mg, 10 mg tablets or capsules online on Advantage Home Telehealth, Inc. website:

Prices:from $0.29 per pill
Discount:10% coupon: DFHDCC
Forms:Glucotrol and Glucotrol-XL tablets 5 mg, 10 mg
Quantity:30-360 pills
Type:Glipizide brand, Glucotrol generic, Glucotrol-XL generic
Payment:Visa, Mastercard, AmEx, E-Check (ACH), Bitcoin
Delivery:Regular and express mail service
Shipping:Worldwide, including USA, UK, Europe, Canada, Australia

Glipizide (trade names include Glucotrol, Glibenese, Glibetic, Glucotrol XL, Glynase, Mindiab, Minidiab) is an oral rapid- and short-acting antidiabetic medication from sulfonylureas pharmacological group. This medicine is used for treating type 2 diabetes in patients who cannot control blood sugar levels only by diet and exercises. It works by causing the pancreas to release insulin, which helps to lower blood sugar and helps your body to use insulin better. Glipizide is used alone or in combined therapy with other antidiabetic drugs, a diabetic diet and exercises.

Glucotrol (Glipizide)

Related medications:

  • Acarbose (Precose)
  • Acetohexamide (Dymelor)
  • Carbutamide (Invenol)
  • Chlorpropamide (Diabinese)
  • Glibornuride (Glutril)
  • Gliclazide (Diamicron)
  • Glimepiride (Amaryl)
  • Glipizide, Metformin (Metaglip)
  • Gliquidone (Glurenorm)
  • Glisoxepide (Pro-Diaban)
  • Glyburide (Micronase)
  • Glyburide, Metformin (Glucovance)
  • Metformin (Glucophage XR)
  • Metformin, Sitagliptin (Janumet)
  • Nateglinide (Starlix)
  • Repaglinide (Prandin)
  • Saxagliptin (Onglyza)
  • Sitagliptin (Januvia)
  • Tolazamide (Tolinase)
  • Tolbutamide (Rastinone)

    Pharmacological and medical categories:

  • Antidiabetic drugs
  • Medications for the treatment of diabetes type 2
  • Oral antidiabetic agents
  • Second-generation sulfonylureas
  • Sulfonylurea derivatives

    ATC codes:

  • A - Alimentary tract and metabolism
  • A10 - Drugs used in diabetes
  • A10B - Blood glucose lowering drugs, excl. insulins
  • A10BB - Sulfonylureas
  • A10BB07 - Glipizide

    ICD-10 codes:

  • Non-insulin-dependent diabetes mellitus - E11

    Indications and usage:

    Glucotrol and Glucotrol XL (Glipizide) tablets are a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

    Limitations of use: not for treatment of type 1 diabetes or diabetic ketoacidosis.

    Dosage and administration:

  • Recommended starting dose of glipizide is 5 mg once daily. Dose adjustment can be made based on the patient's glycemic control. Maximum recommended dose is 20 mg once daily.
  • Administer with breakfast or the first meal of the day.
  • For combination therapy with other blood-glucose-lowering agents, initiate the agent at the lowest recommended dose, and observe pati ents for hypoglycemia.

    Dosage forms and strengt:

  • Glucotrol (Glipizide) tablets: 5 mg, 10 mg.
  • Glucotrol XL (Glipizide) extended release tablets: 2.5 mg, 5 mg, 10 mg.


    Overdosage of sulfonylureas including Glipizide (Glucotrol and Glucotrol XL) can produce severe hypoglycemia. Mild hypoglycemic symptoms without loss of consciousness or neurologic findings should be treated with oral glucose. Severe hypoglycemic rea ctions with coma, seizure, or other neurological impairment are medical emergencies requiring immediate treatment. The patient should be trea ted with gluca gon or intra venous glucose. Patients should be closely monitored for a minimum of 24 to 48 hours since hypoglycemia may recur a fter a pparent clinical recovery. Clearance of glipizide from pla sma may be prolonged in persons with liver disease. Because of the extensive protein binding of glipizide, dialysis is unlikely to be of benefit.


  • Known hypersensitivity to glipizide or any of the product's ingredients.
  • Hypersensitivity to sulfonamide derivatives.

    Warnings and precautions:

  • Hypoglycemia: may be severe. Ensure proper patient selection, dosing, and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications.
  • Hemolytic anemia: can occur if glucose 6-phosphate dehydrogenase (G6PD) deficient. Consider a non-sulfonylurea alternative.
  • Potential increased risk of cardiovascular mortality with sulfonylureas: inform patient of risks, benefits and treatment alternatives.
  • Macrovascular outcomes: no clinical studies have established conclusive evidence of macrovascular risk reduction with glipizide or any other anti-diabetic drug.

    Adverse reactions, side effects:

    Most common adverse reactions (incidence > 3%) of glipizide are dizziness, diarrhea, nervousness, tremor, hypoglycemia and flatulence.

    To report suspected side effects of Glucotrol or Glucotrol XL (Glipizide) tablets contact Pfizer pharmaceutical company, or your local FDA.

    Drug abuse and dependence:

  • Certain medications may affect glucose metabolism, requiring Glucotrol XL dose adjustment and close monitoring of blood glucose.
  • Miconazole: monitor patients closely. Severe hypoglycemia can occur when Glucotrol and oral miconazole are used concomitantly.
  • Fluconazole: monitor patients closely. An increase in Glucotrol AUC was seen after fluconazole administration.
  • Colesevelam: Glucotrol XL should be administered at least 4 hours prior to colesevelam.

    Use in specific populations:

    Geriatric, hepatically impaired patients: at risk for hypoglycemia with glipizide pills. Use caution in dose selection and titration, and monitor closely.

    Patient counseling information:

    Advise the patient to read the FDA-a pproved patient labeling.

    Inform patients of the potential adverse reactions of Glucotrol and Glucotrol XL including hypoglycemia. Explain the risks of hypoglycemia, its symptoms and treatment, and conditions that predispose to its development to patients and responsible family members. Also inform patients about the importance of adhering to dietary instructions, of a regular exercise program, and of regular testing of glycemic control.

    Inform patients that glipizide tablets should be swallowed whole. Inform patients that they should not chew, divide or crush tablets and they may occasionally notice in their stool something that looks like a tablet. In the Glucotrol XL tablet, the medication is contained within a non-dissolvable shell that has been specially designed to slowly release the drug so the body can absorb it.


    Advise females of reproductive potential to inform their prescriber of a known or suspected pregnancy.


    Advise breastfeeding women taking Glipizide (Glucotrol, Glucotrol XL) pills to monitor breastfed infants for signs of hypoglycemia (e.g., jitters, cyanosis, hypothermia, excessive sleepiness, poor feeding, seizures).

    Pregnancy categories:

  • C - Australia
  • C - United States (Risk cannot be ruled out)

    Salts and other forms:

  • Glipizide Base

    Synonyms, international and chemical names:

  • Glipitsidi
  • Glipizid
  • Glipizida
  • Glipizidum
  • Glipizyd
  • Glupizide
  • Glydiazinamide
  • Glypizide

    Brands, generics, trade names:

  • Dipazide - Siam Pharmaceutical
  • Glez - Aristo Pharmaceuticals
  • Glibenese - Pfizer, Dexo Laboratoire
  • Glibetic - La Pharmaceuticals
  • Glidiab - Kai Yuen Pharmaceuticals
  • Glipizid - Domesco Medical Import-Export
  • Glipizide - Alphapharm, Drug Houses of Australia, IVAX, Merck, Mylan, Pliva, Sandoz, Teva
  • Gluco-Rite - Perrigo
  • Glucotrol - Pfizer
  • Glucotrol-XL - Pfizer
  • Glynase - USV
  • Luditec - Collins Productos Farmaceuticos
  • Melizide - Merck, Alphapharm, Serono, Summit, Zuellig Pharma
  • Mindiab - Pfizer
  • Minidiab - Pfizer
  • Minodiab - Pfizer, Kenfarma
  • Ozidia - Pfizer
  • Semi-Glynase - USV

    APIs used in medicine in combinations with glipizide:

  • Metformin

    Here is a list of popular medications containing glipizide as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
  • Tablets; Oral; Glipizide 2.5 mg
  • Tablets; Oral; Glipizide 5 mg
  • Tablets; Oral; Glipizide 10 mg
  • Pfizer
  • Jenburkt Pharmaceuticals
  • Roerig
  • Glucotrol-XL
  • Tablets, Extended Release; Oral; Glipizide 2.5 mg
  • Tablets, Extended Release; Oral; Glipizide 5 mg
  • Tablets, Extended Release; Oral; Glipizide 10 mg
  • Pfizer
  • DCH Auriga
  • Roerig
  • Zuellig Pharma
  • Glynase
  • Tablets; Oral; Glipizide 1.5 mg
  • Tablets; Oral; Glipizide 2.5 mg
  • Tablets; Oral; Glipizide 5 mg
  • USV
  • Condor Healthcare
  • Minidiab
  • Tablets; Oral; Glipizide 2.5 mg
  • Tablets; Oral; Glipizide 5 mg
  • Pfizer
  • Chemical Industries Development
  • Dexo Laboratoire
  • DKSH Distribution
  • Flex Pharma
  • Laphal Industries
  • Primal Chemical
  • The Glory Medicina
  • Zentiva
  • Zuellig Pharma

  • References:

  • Glipizide main article on Wikipedia:
  • Glipizide compound on PubChem:
  • Glipizide medicine on DrugBank:
  • Glipizide FAQ on MedlinePlus (revised 10/15/2017):
  • Drug-induced low blood sugar on MedlinePlus (revised 10/11/2020):
  • Glipizide tablets drug label info on DailyMed (revised January 23, 2015):
  • Glipizide ER film-coated extended-release tablets drug label info on DailyMed (revised November 22, 2019):
  • Glipizide XL extended-release tablets drug label info on DailyMed (revised May 24, 2021):
  • Glucotrol (Glipizide) tablets drug label info on DailyMed (revised June 7, 2021):
  • Glucotrol XL (Glipizide) extended-release tablets drug label info on DailyMed (revised August 17, 2018):
  • Glipizide containing drugs on
  • Glipizide for sale on Pharma Doctor:
  • Glucotrol (Glipizide) tablets 5 mg, 10 mg official prescribing information from the U.S. FDA (revised September 2008):
  • Glucotrol XL (Glipizide) 2.5 mg, 5 mg, 10 mg extended release tablets for oral use official prescribing and patient information from the U.S. FDA (revised 10/2015):
  • Glucotrol (Glipizide) tablets prescribing information from Pfizer pharmaceutical company (revised 10/2016):
  • Glucotrol XL (Glipizide) tablets extended release prescribing and patient information from Pfizer pharmaceutical company (revised 05/2021):
  • Minidiab (Glipizide) 5 mg tablets consumer medicine information from NPS MedicineWise (revised October 2019):
  • Minodiab (Glipizide) 5 mg tablets information leaflet from (revised 08/2016):

    Revised: July 2021

    Home | About Us | Team | Solutions for Hospitals | Solutions for Home Health Agencies | Solutions for Self-Care | Solutions for Corporations | Contact

    Copyright © 2008 - 2021 Advantage Home Telehealth, Inc. All Rights Reserved.